205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.88%
Revenue growth at 50-75% of MRVL's 4.29%. Martin Whitman would worry about competitiveness or product relevance.
27.53%
Gross profit growth above 1.5x MRVL's 3.82%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-95.92%
Negative EBIT growth while MRVL is at 8.09%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-95.92%
Negative operating income growth while MRVL is at 15.99%. Joel Greenblatt would press for urgent turnaround measures.
22.34%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
36.36%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
36.36%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.19%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.28%
Diluted share reduction more than 1.5x MRVL's 1.17%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.19%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-45.94%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-90.99%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
103.46%
10Y revenue/share CAGR above 1.5x MRVL's 56.20%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
63.64%
5Y revenue/share CAGR at 50-75% of MRVL's 109.65%. Martin Whitman would worry about a lagging mid-term growth trajectory.
9.95%
3Y revenue/share CAGR under 50% of MRVL's 25.49%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
169.26%
5Y OCF/share CAGR above 1.5x MRVL's 45.44%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
1795.38%
3Y OCF/share CAGR above 1.5x MRVL's 63.72%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1540.34%
Net income/share CAGR above 1.5x MRVL's 653.69% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
1453.85%
5Y net income/share CAGR above 1.5x MRVL's 220.76%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
274.20%
3Y net income/share CAGR 1.25-1.5x MRVL's 202.86%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
16.10%
5Y equity/share CAGR at 75-90% of MRVL's 19.67%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
11.87%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-15.83%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-42.43%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
15.40%
AR growth well above MRVL's 11.24%. Michael Burry fears inflated revenue or higher default risk in the near future.
7.03%
Inventory growth well above MRVL's 4.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.18%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
7.50%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
3.05%
Debt growth far above MRVL's 3.89%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-12.80%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.